Macfarlanes has advised 17Capital. 17Capital has announced the final closing of its 17Capital Strategic Lending Fund 6, reaching total commitments of $5.5 billion. The total includes...
17Capital Closes Strategic Lending Fund 6 at $5.5 Billion
Alchemy’s €1 Billion Closing of Alchemy Special Opportunities Fund V (ASOF V)
Macfarlanes advised Alchemy Partners on the deal. Alchemy Partners closed its latest fund, Alchemy Special Opportunities Fund V, securing €1bn in capital commitments and surpassing its...
Signal Capital Partners’ Strategic Parntership With Armen
Macfarlanes advised Signal Capital Partners on the deal. Signal Capital Partners, a leading private asset management firm focused on private credit solutions for European corporate and...
Volpi Capital’s Closing of Volpi Capital Investments Conti LP
Macfarlanes has advised Volpi Capital LLP. Volpi Capital LLP, a specialist European lower mid-market private equity firm, establishmed and closed Volpi Capital Investments Conti LP. The new continuation...
Synova’s £875 Million Fifth Fundraising
Macfarlanes has advised UK-based private equity firm Synova. The new fund, which reached its cap in only three months, will continue Synova’s investment strategy of investing...
Northern Gritstone’s £215 Million Initial Fundraising
Macfarlanes and Pinsent Masons advised Northern Gritstone on the deal. Northern Gritstone, a new investment business focused on university spinouts in the north of England, raised...
Apache Capital’s £610 Million Joint Venture with KKR
Macfarlanes and Trowers & Hamlins advised property investment firm Apache Capital Partners on the deal. Apache Capital Partners established a joint venture with KKR to create...
Tembo Capital Management’s $380 Million Fundraising
Macfarlanes has advised Tembo Capital Management on the deal. Tembo Capital Management, a leading investment advisor in the metals and mining sector, on its third fund,...
17Capital’s $2.9 Billion Fundraising
Macfarlanes has advised 17Capital on its fifth fund, 17Capital Fund 5, which has successfully held a final closing at its hard cap. The fund provides preferred...
Signal Capital Partners’ €900 Million Fundraising
Macfarlanes advised Signal Capital Partners on the fundraising. The Signal Alpha II fund, which is one of the largest dedicated special situations funds in Europe, exceeded its...
Advent Life Sciences’ €215 Million Fundraising
Macfarlanes has advised Advent Life Sciences on the transaction. Advent Life Sciences raised two new life sciences-focused funds, Advent Life Sciences Fund III and the Advent-Harrington Impact...